The ACCORD (Action to Control Cardiovascular Risk in Diabetes) Lipid Trial What we learn from subgroup analyses

被引：54
作者：
Ginsberg, Henry N. [1 ,2 ]
机构：
[1] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10027 USA
[2] Columbia Univ, Coll Phys & Surg, Irving Inst Clin & Translat Res, New York, NY USA
来源：
DIABETES CARE | 2011年 / 34卷
关键词：
CORONARY-HEART-DISEASE; LDL CHOLESTEROL; INTERVENTION; MEN; GEMFIBROZIL; PREVENTION; MORTALITY; THERAPY; PEOPLE;
D O I：
10.2337/dc11-s203
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S107 / S108
页数：2
相关论文
共 14 条
  • [1] Action to control cardiovascular risk in diabetes (ACCORD) trial: Design and methods
    Buse, John B.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (12A) : 21I - 33I
  • [2] Diabetic dyslipidemia
    Chahil, Tina J.
    Ginsberg, Henry N.
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2006, 35 (03) : 491 - +
  • [3] Collins R, 2003, LANCET, V361, P2005
  • [4] HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE
    FRICK, MH
    ELO, O
    HAAPA, K
    HEINONEN, OP
    HEINSALMI, P
    HELO, P
    HUTTUNEN, JK
    KAITANIEMI, P
    KOSKINEN, P
    MANNINEN, V
    MAENPAA, H
    MALKONEN, M
    MANTTARI, M
    NOROLA, S
    PASTERNACK, A
    PIKKARAINEN, J
    ROMO, M
    SJOBLOM, T
    NIKKILA, EA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) : 1237 - 1245
  • [5] Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282
  • [6] Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
    Haffner, SM
    Lehto, S
    Rönnemaa, T
    Pyörälä, K
    Laakso, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (04) : 229 - 234
  • [7] Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study):: randomised controlled trial
    Keech, A
    Simes, RJ
    Barter, P
    Best, J
    Scott, R
    Taskinen, MR
    Forder, P
    Pillai, A
    Davis, T
    Glasziou, P
    Drury, P
    Kesäniemi, YA
    Sullivan, D
    Hunt, D
    Colman, P
    d'Emden, M
    Whiting, M
    Ehnholm, C
    Laakso, M
    [J]. LANCET, 2005, 366 (9500) : 1849 - 1861
  • [8] JOINT EFFECTS OF SERUM TRIGLYCERIDE AND LDL CHOLESTEROL AND HDL CHOLESTEROL CONCENTRATIONS ON CORONARY HEART-DISEASE RISK IN THE HELSINKI HEART-STUDY - IMPLICATIONS FOR TREATMENT
    MANNINEN, V
    TENKANEN, L
    KOSKINEN, P
    HUTTUNEN, JK
    MANTTARI, M
    HEINONEN, OP
    FRICK, MH
    [J]. CIRCULATION, 1992, 85 (01) : 37 - 45
  • [9] Diabetes, plasma insulin, and cardiovascular disease - Subgroup analysis from the Department of Veterans Affairs High-Density Lipoprotein Intervention Trial (VA-HIT)
    Rubins, HB
    Robins, SJ
    Collins, D
    Nelson, DB
    Elam, MB
    Schaefer, EJ
    Faas, FH
    Anderson, JW
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (22) : 2597 - 2604
  • [10] Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
    Rubins, HB
    Robins, SJ
    Collins, D
    Fye, CL
    Anderson, JW
    Elam, MB
    Faas, FH
    Linares, E
    Schaefer, EJ
    Schectman, G
    Wilt, TJ
    Wittes, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (06) : 410 - 418
12